Enrolling by invitationPHASE1, PHASE2NCT07163299

Intra-arterial Selective Hypothermic Magnesium Sulfate Infusion in Combination With Endovascular Thrombectomy in Acute Ischemic Stroke

Studying Acute graft versus host disease

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Capital Medical University
Intervention
Endovascular thrombectomy combination with selective intra-arterial hypothermic magnesium sulfate infusion (350 ml).(procedure)
Enrollment
42 target
Eligibility
18-80 years · All sexes
Timeline
2025 – 2027

Study locations (1)

Collaborators

The Affiliated Hospital of Xuzhou Medical University

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07163299 on ClinicalTrials.gov

Other trials for Acute graft versus host disease

Additional recruiting or active studies for the same condition.

See all trials for Acute graft versus host disease →

← Back to all trials